Delpharm SRL
Delpharm reported total assets of €1.29m at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026).
The score of Delpharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +170 % Total assets +6 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Delpharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 07 Jun 2024
- Year ended 31 Dec 2022filed on 24 May 2023
Delpharm's financial analysis
- Solvency27.2%sector median: 49.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Delpharm
Delpharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0763.567.469
- VAT number
- BE0763567469
- Peppol
- Registered · 0208:0763567469 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Feb 2021
- Registered office
- 4540 Amay
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Delpharm (SRL) has been based in Amay since 2021, active in: business and other management consultancy activities. For 2025, it reports a net profit of 34,356 € and equity of 350,889 €; its revenue is not published. Its solvency stands at 27.2%, below the median of its sector (49.1%).
Companies similar to Delpharm
Companies in the same business, of comparable size and area, outside its group.
- Pharmare Business and other management consultancy activities De Haan · balance sheet €1.29m
- Amlibo Business and other management consultancy activities Ninove · balance sheet €1.29m
- Wouters Management Business and other management consultancy activities Beringen · balance sheet €1.29m
- MF Management Business and other management consultancy activities Fléron · balance sheet €1.29m
- Retail LMC Business and other management consultancy activities Étalle · balance sheet €1.34m
- Galwico Business and other management consultancy activities Tongeren-Borgloon · balance sheet €1.29m
- THE Concord Group Business and other management consultancy activities Leuven · balance sheet €1.29m
- Nijasu Business and other management consultancy activities Theux · balance sheet €1.29m
Frequently asked questions about Delpharm
What is the revenue of Delpharm?
Delpharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Delpharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0763567469 for Delpharm, if the company is VAT-registered. Its company number (CBE) is 0763.567.469.
Where is the registered office of Delpharm?
According to the CBE register, the registered office of Delpharm is in 4540 Amay.
What is the equity of Delpharm?
At the close of the 2025 financial year, the equity of Delpharm amounts to 350,889 €, a solvency of 27.2% of total assets.
Who manages Delpharm?
The register lists 1 active mandates at Delpharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Delpharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →